RVPHealthcare · Medical Instruments & SuppliesRVP Stock Forecast: Retractable Technologies, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 67 of 100 as at 1 Aug 2026 — in the upper half.
RVP stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Retractable Technologies, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (98): Sales and profits are climbing, and climbing faster than before.
Value (14): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own Retractable Technologies, Inc. — and when they’d sell — is the membership.
RVP stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on RVP, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
RVP analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Retractable Technologies, Inc. (RVP) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 8.1×
- Price / sales
- 0.5×
- Price / book
- 0.3×
- EV / EBITDA
- 1.0×
Cheaper than 62% of US stocks
Cheaper than 82% of US stocks
Cheaper than 88% of US stocks
Cheaper than 58% of US stocks
- Revenue growth (YoY)
- −13.5%
- Earnings growth (YoY)
- —
- Gross margin
- −11.7%
- Operating margin
- −85.9%
- Net margin
- −16.9%
Higher than 13% of US stocks
Higher than 4% of US stocks
Higher than 15% of US stocks
Higher than 16% of US stocks
- Return on equity
- −8.6%
- Return on assets
- −9.5%
- Dividend yield
- —
Higher than 36% of US stocks
Higher than 27% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
RVP vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. RVP appears on the weeks it earns a place.
Frequently asked questions about RVP stock
How does Ticker Nerd's model rank RVP?
As at 1 Aug 2026, Retractable Technologies, Inc. ranks 67 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (98 of 100).
What is the RVP stock forecast for 2030?
No analyst covering Retractable Technologies, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for RVP are extrapolating price history, which says nothing about the business.
How has RVP stock performed over the past year?
Retractable Technologies, Inc. returned -10.8% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Retractable Technologies, Inc. do?
Retractable Technologies Inc. is a prominent player in the medical device industry, known for its commitment to improve safety in medical environments.
About Retractable Technologies, Inc.
Retractable Technologies Inc. is a prominent player in the medical device industry, known for its commitment to improve safety in medical environments. The company specializes in the design, manufacturing, and marketing of safety medical devices, with its primary products being retractable and injection needle systems. These innovative devices are crafted to minimize risks of accidental needle-stick injuries and reduce opportunities for cross-contamination, thereby enhancing safety for healthcare professionals and patients alike. Retractable Technologies Inc.'s products cater to hospitals, clinics, medical facilities, and other healthcare providers across the globe. By providing solutions that address critical safety issues in healthcare settings, the company plays a vital role in public health and safety. With a focus on technological innovation and quality, Retractable Technologies Inc. continues to influence best practices in medical device safety, contributing to safer clinical outcomes and nurturing trust within the healthcare industry.
CEO Mr. Thomas J. Shaw · 195 employees · United States · https://www.retractable.com